Home > Insider Trading > Filing (0001213900-25-051685)

Filing Details

Accession Number:: 0001213900-25-051685
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2025-06-05 19:05:23
Reporting Period:: 2025-03-26

Filing Date:: 2025-06-05
Accepted Time:: 2025-06-05 19:05:23
Original Submission Date:: 2025-03-28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1979414	Neonc Technologies Holdings Inc.	NTHI	Pharmaceutical Preparations (2834)	921954864

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1998682	C Thomas Chen	23975 Sorrento Park Suite 205 Calabasas CA 91302	Ceo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-03-26	4,076	$0.00	220,787	No	4	J	Indirect	By HCWG LLC.
Common Stock	Acquisiton	2025-03-26	79,688	$12.00	300,475	No	4	X	Indirect	By HCWG LLC
Common Stock	Disposition	2025-03-26	38,250	$25.00	262,225	No	4	S	Indirect	By HCWG LLC
Common Stock	Disposition	2025-03-26	983	$19.13	261,242	No	4	S	Indirect	By HCWG LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Indirect	By HCWG LLC.
No	4	X	Indirect	By HCWG LLC
No	4	S	Indirect	By HCWG LLC
No	4	S	Indirect	By HCWG LLC

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (right to buy)	Disposition	2025-03-26	79,688	$0.00	79,688	$12.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2025-03-26		No	4	X	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	545,800	Indirect	See footnote 6.
Common Stock	888,148	Indirect	By NeuCen Biomedical Co. Ltd.
Common Stock	2,833,961	Indirect	By TR Chen Third Family Limited Partnership.
Common Stock	93,253	Indirect	By Tien Duan Chen Trust.

Footnotes

Transfer of shares of common stock held by HCWG LLC pursuant to agreement.
Not applicable. Number of shares transferred was based on a per share value of $18.
The shares reported herein represent only Reporting Person's percentage interest in HCWG LLC.
On 3/26/2025, in conjunction with Issuer's initial listing on Nasdaq, HCWG exercised a warrant to purchase 312,500 shares of Issuer's common stock at $12 per share. HCWG paid the exercise price on a cashless basis, resulting in Issuer's withholding 150,000 of the warrant shares to pay the exercise price and issuing to HCWG the remaining 162,500 shares of common stock. Number of shares reported herein as acquired and disposed of by the Reporting Person represents Reporting Person's indirect interest in HCWG.
In connection with HCWG's cashless exercise of the warrant described herein, Reporting Person paid his proportionate share of the exercise price on a cashless basis. Reporting Person's proportionate withholding from shares issued to HCWG totaled 38,250 warrant shares to pay the exercise price.
Includes shares of common stock held by certain members of Reporting Person's immediate family of which Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest, if any, therein.
Shares held by NeuCen Biomedical Co. Ltd. ("NeuCen"). NeuCen is owned in part by Reporting Person's spouse. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
Shares held by T. R. Chen Third Family Limited Partnership, a NV limited partnership, of which Reporting Person and his spouse are the general partners with sole voting and dispositive power. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
Not applicable.